A Case of Myocarditis Presenting With a Hyperechoic Nodule After the First Dose of COVID-19 mRNA Vaccine

A Case of Myocarditis Presenting With a Hyperechoic Nodule After the First Dose of COVID-19 mRNA Vaccine

Myocarditis and/or pericarditis have been reported as adverse events following coronavirus disease 2019 (COVID-19) messenger RNA vaccination, with most cases occurring within 1 week after the second dose. We report a rare case of myocarditis after the first dose of the BNT162b2 (Pfizer-BioNTech) COV...

Full description

Bibliographic Details
Main Authors: Park, S. (Author), You, J. (Author)
Format: Article
Language:English
Published: NLM (Medline) 2022
Subjects:
Adolescent
case report
COVID-19
mRNA Vaccines
Myocarditis
Online Access:View Fulltext in Publisher
Description
Summary:Myocarditis and/or pericarditis have been reported as adverse events following coronavirus disease 2019 (COVID-19) messenger RNA vaccination, with most cases occurring within 1 week after the second dose. We report a rare case of myocarditis after the first dose of the BNT162b2 (Pfizer-BioNTech) COVID-19 vaccine in a 17-year-old boy. Here, we describe the laboratory, electrocardiographic, and imaging findings of myocarditis. © 2022 The Korean Academy of Medical Sciences.
ISBN:15986357 (ISSN)
DOI:10.3346/jkms.2022.37.e131

Similar Items